Meet Back Bay Life Science Advisors at BioNetwork Partnering Summit 2018

Back Bay’s team of life science industry experts will be at the 2018 BioNetwork Partnering Summit, October 10-12. Laguna Niguel, CA. Back Bay co-sponsors the event and will moderate several panels on advances in immuno-therapy, federal policy and deal-making, and due diligence.Contact Back Bay Life Science Advisors to schedule a meeting at BioNetwork Partnering Summit or to ask questions about the panel topics: info@bblsa.com 

Current State of Pharma & Federal Policy

Moderated by Back Bay Senior Vice President, Strategy Consulting, Christopher Leo, PhD

• What are the implications of recent proposals by the current administration?

• What is the activity we’ve seen since the tax reform earlier this year?

• What can we expect in terms of pharma deal-making over the next year?

• What have been some impacts of the changes in the FDA in the past couple of years?

The Future of Combination Immuno-Oncology

Moderated by Back Bay Senior Vice President, Strategy Consulting, Michelle Hoffmann, PhD

• What are the obstacles in combination IO deal-making?

• What are some innovative deal structures that have happened in the space?

• Beyond PD1, what are the exciting opportunities companies are pursuing?

• Is there an opportunity to advance pricing and what are the legal and commercial aspects?

Mastering the Science of Due Diligence

Moderated by Back Bay Managing Partner and CEO, Jonathan Gertler, MD

• What are the key challenges in conducting diligence?

• How are some of these challenges best overcome?

• What are the most effective approaches in getting validated insights faster?

 View the agenda and register for BioNetwork Partnering at bionetwork.wbresearch.com